Trial Profile
Oseltamivir Pharmacokinetics in Morbid Obesity.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 15 May 2015
Price :
$35
*
At a glance
- Drugs Oseltamivir (Primary)
- Indications Influenza virus infections
- Focus Pharmacokinetics
- Acronyms OPTIMO
- 02 Aug 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 06 Nov 2009 New trial record